Divi's Laboratories Limited
DIVISLABDrug Manufacturers - Specialty & Generic
₹9,664.00+1.10%As of Oct 29vs prior close
- Market cap
- $26.9B
- P/E (TTM)
- 87.7×
- P/E (FY1)
- 78.3×
- From 52W high
- 0.00%
- EPS (LTM)
- ₹110.21
- Revenue (LTM)
- ₹112.3B
- Net margin
- 26.05%
- Dividend yield
- 0.31%
Nomior Score
67
Crowded AscentTop 13% of the scored universe
Growth66
Quality62
Value26
Momentum82
Resilience68
Growth
+10.98%revenue a year over 3 fiscal years
YE23 ₹76.7BLTM ₹112.3B
Connections
Revenue to profitYE26
25% of revenue became net profit, up 1 pt on a year.